Skip to main content
Day.News — Local News. Real Community.
COLUMBUS DAY NEWS
Local News. Real Community.
health
1 min read

FDA Identifies False Positive in Cyclospora Outbreak Lettuce Sample

The Food and Drug Administration reported a test sample of Taylor Farms lettuce, previously linked to a cyclospora outbreak, yielded a false positive result. No products have tested positive for the disease, and investigators continue to search for the source.

07/29/2026 · Washington edition

Advertisement

Advertisement

WASHINGTON – The Food and Drug Administration (FDA) announced Saturday that a test sample of Taylor Farms lettuce, initially reported as positive for cyclospora, was a false positive. This development introduces new complexity into the ongoing investigation of a cyclospora outbreak that has sickened thousands across the country.

FDA officials stated that no food products have tested positive for cyclospora in connection with the current outbreak. The agency continues its investigation to determine the source of the contamination.

NBC News correspondent Anne Thompson reported the details for TODAY.

Related Topics

Editorial Transparency
AI-Generated · Written by National Desk

Article Ratings

Factual
0.0
Likeable
0.0
Bias
0.0
Objective
0.0

How do you feel about this story?

NA

National Desk

Trust 3.1102308 articles8,220,515 views75% fact accuracy
View Profile

Sign in to follow this author from their profile.

Discussion (0)

Join the Conversation

Join the conversation

Sign in to share your thoughts, reply to readers, and like comments.

Sign in to comment
Sort by:
0 comments

No comments yet. Be the first to comment!

Trending Now

Trending stories will appear here.

More from Washington

No other local stories are available right now.

Events & Things to Do

Read section →

Upcoming events will appear here.

Advertisement

Advertisement

Keep Reading

Related Stories

More health stories from Washington

health

Cost of GLP-1 Medications Prompts Search for Alternatives

Many Americans face financial hurdles when trying to access GLP-1 medications. These cost barriers have prompted some patients to seek out alternative, unregulated versions. The situation highlights ongoing challenges in prescription drug affordability.

Read Story →
health

Experimental Vaccine Shows Promise Against Glioblastoma

An experimental vaccine for glioblastoma, a severe form of brain cancer, demonstrates potential to prolong life for patients. Developers report encouraging results from ongoing studies.

Read Story →
health

Medicare for All Becomes Midterm Campaign Focus Amid Voter Support

Candidates in midterm elections are increasingly discussing 'Medicare for All.' A recent poll shows two-thirds of Americans support the concept. This reflects a public desire for significant changes in health care.

Read Story →
health

Flu Activity Increases Earlier This Season

Flu season typically begins in October or November. However, reports indicate an increase in influenza activity starting in September this year. This earlier onset prompts consideration of vaccination.

Read Story →
health

Vaping Rises Among Non-Smokers in UK, Surpassing Smoking Rates for Second Year

New data indicates one million individuals in the UK, who have no history of smoking, now use e-cigarettes. For the second consecutive year, more people aged 16 and over report vaping than smoking.

Read Story →
health

GLP-1 Medications See Increased Use, Spur Research into New Applications

GLP-1 medications are now used by an estimated one in eight Americans. Researchers continue to investigate new potential applications for these drugs. The expansion in use prompts further questions and research.

Read Story →
Scroll for more stories